Previous close | 0.0600 |
Open | 0.0800 |
Bid | 0.0500 |
Ask | 0.0600 |
Strike | 50.00 |
Expiry date | 2023-06-16 |
Day's range | 0.0500 - 0.0800 |
Contract range | N/A |
Volume | |
Open interest | 32.66k |
AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) are two of the world's biggest pharmaceutical companies, and the similarities don't end there. The case for AbbVie as a growth stock can't avoid two issues: the decline of Humira, and the stagnation of its oncology portfolio.
BNTX is ranked a lowly 5 for a reason. Earnings have peaked, COVID hysteria has subsided, and the technical picture is lagging.
In the latest trading session, Pfizer (PFE) closed at $40.22, marking a -0.42% move from the previous day.